Kamaldeep Panach, M.d., Inc. | |
29826 Haun Rd Ste 302 Menifee CA 92586-6547 | |
(951) 672-1911 | |
Not Available |
Full Name | Kamaldeep Panach, M.d., Inc. |
---|---|
Speciality | Internal Medicine |
Location | 29826 Haun Rd Ste 302, Menifee, California |
Authorized Official Name and Position | Kamaldeep Panach (PRESIDENT) |
Authorized Official Contact | 5593019209 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Kamaldeep Panach, M.d., Inc. 10260 W Shields Ave Fresno CA 93723-9612 Ph: (559) 301-9209 | Kamaldeep Panach, M.d., Inc. 29826 Haun Rd Ste 302 Menifee CA 92586-6547 Ph: (951) 672-1911 |
NPI Number | 1386301687 |
---|---|
Provider Enumeration Date | 11/21/2021 |
Last Update Date | 11/21/2021 |
Medicare PECOS PAC ID | 2860884103 |
---|---|
Medicare Enrollment ID | O20220119001893 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The HIMSS Electronic Health Record Association has submitted its detailed responses on two major regulations that implement healthcare IT incentive provisions of the American Recovery and Reinvestment Act of 2009 (ARRA).
An antidepressant can alleviate symptoms of major depression in women experiencing or about to experience menopause, according to a study released today led by a Virginia Commonwealth University researcher.
Variations in the way states have moved to implement the 2010 federal health-care law have taken on greater significance after last week's Supreme Court hearings, whose tone heightened speculation that the statute would be overturned.
› Verified 5 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1386301687 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | (* (Not Available)) | Primary |
Provider Name | Kamaldeep Panach |
---|---|
Provider Type | Practitioner - Internal Medicine |
Provider Identifiers | NPI Number: 1043501174 PECOS PAC ID: 3476771320 Enrollment ID: I20191029000763 |
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The HIMSS Electronic Health Record Association has submitted its detailed responses on two major regulations that implement healthcare IT incentive provisions of the American Recovery and Reinvestment Act of 2009 (ARRA).
An antidepressant can alleviate symptoms of major depression in women experiencing or about to experience menopause, according to a study released today led by a Virginia Commonwealth University researcher.
Variations in the way states have moved to implement the 2010 federal health-care law have taken on greater significance after last week's Supreme Court hearings, whose tone heightened speculation that the statute would be overturned.
› Verified 5 days ago
News Archive
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.
The HIMSS Electronic Health Record Association has submitted its detailed responses on two major regulations that implement healthcare IT incentive provisions of the American Recovery and Reinvestment Act of 2009 (ARRA).
An antidepressant can alleviate symptoms of major depression in women experiencing or about to experience menopause, according to a study released today led by a Virginia Commonwealth University researcher.
Variations in the way states have moved to implement the 2010 federal health-care law have taken on greater significance after last week's Supreme Court hearings, whose tone heightened speculation that the statute would be overturned.
› Verified 5 days ago
Premier Hospitalist & Post-acute Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 29826 Haun Rd, Suite102, Menifee, CA 92586 Phone: 951-672-4900 Fax: 888-410-4699 | |
James P. Krieg M.d., Med Corp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 29826 Haun Rd, Suite 203, Menifee, CA 92586 Phone: 951-672-1911 Fax: 951-672-8406 | |
Zebarjadi Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 27819 Sagebrush Rd, Menifee, CA 92585 Phone: 415-827-1483 | |
Seven Star Medical Group Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 28400 Mccall Blvd # B10, Menifee, CA 92585 Phone: 951-414-4021 | |
Patrick & Edivina Gonzales Medical Group Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 29798 Haun Rd, Suite 106, Menifee, CA 92586 Phone: 951-301-3588 Fax: 951-301-4309 | |
Neighborhood Healthcare Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 26926 Cherry Hills Blvd Ste C, Menifee, CA 92586 Phone: 833-867-4642 |